Cleo Diagnostics Statistics
Total Valuation
ASX:COV has a market cap or net worth of AUD 56.54 million. The enterprise value is 49.23 million.
Market Cap | 56.54M |
Enterprise Value | 49.23M |
Important Dates
The next estimated earnings date is Wednesday, May 28, 2025.
Earnings Date | May 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ASX:COV has 128.50 million shares outstanding. The number of shares has increased by 25.28% in one year.
Current Share Class | n/a |
Shares Outstanding | 128.50M |
Shares Change (YoY) | +25.28% |
Shares Change (QoQ) | +10.23% |
Owned by Insiders (%) | 32.04% |
Owned by Institutions (%) | n/a |
Float | 73.01M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 268.20 |
PB Ratio | 7.60 |
P/TBV Ratio | 8.01 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -15.89 |
EV / Sales | 233.52 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -17.60 |
Financial Position
The company has a current ratio of 16.70
Current Ratio | 16.70 |
Quick Ratio | 16.51 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -34.46% and return on invested capital (ROIC) is -22.24%.
Return on Equity (ROE) | -34.46% |
Return on Assets (ROA) | -21.46% |
Return on Invested Capital (ROIC) | -22.24% |
Return on Capital Employed (ROCE) | -42.98% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.02 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +148.65% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +148.65% |
50-Day Moving Average | 0.44 |
200-Day Moving Average | 0.38 |
Relative Strength Index (RSI) | 54.03 |
Average Volume (20 Days) | 153,465 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:COV had revenue of AUD 210,812 and -3.10 million in losses. Loss per share was -0.03.
Revenue | 210,812 |
Gross Profit | 210,812 |
Operating Income | -3.20M |
Pretax Income | -3.10M |
Net Income | -3.10M |
EBITDA | -3.14M |
EBIT | -3.20M |
Loss Per Share | -0.03 |
Balance Sheet
The company has 7.31 million in cash and n/a in debt, giving a net cash position of 7.31 million or 0.06 per share.
Cash & Cash Equivalents | 7.31M |
Total Debt | n/a |
Net Cash | 7.31M |
Net Cash Per Share | 0.06 |
Equity (Book Value) | 7.44M |
Book Value Per Share | 0.06 |
Working Capital | 7.03M |
Cash Flow
In the last 12 months, operating cash flow was -2.79 million and capital expenditures -2,563, giving a free cash flow of -2.80 million.
Operating Cash Flow | -2.79M |
Capital Expenditures | -2,563 |
Free Cash Flow | -2.80M |
FCF Per Share | -0.02 |
Margins
Gross Margin | 100.00% |
Operating Margin | -1,517.30% |
Pretax Margin | -1,469.73% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ASX:COV does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -25.28% |
Shareholder Yield | -25.28% |
Earnings Yield | -5.48% |
FCF Yield | -4.95% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
ASX:COV has an Altman Z-Score of 50.4.
Altman Z-Score | 50.4 |
Piotroski F-Score | n/a |